Kabiven FDA Approval History
FDA Approved: Yes (First approved August 25, 2014)
Brand name: Kabiven
Generic name: amino acids, electrolytes, dextrose and lipid
Dosage form: Injectable Emulsion
Company: Fresenius Kabi USA, LLC
Treatment for: Parenteral Nutrition
Kabiven (amino acids, electrolytes, dextrose and lipid injectable emulsion) is indicated as a source of calories, protein, electrolytes and essential fatty acids for adult patients requiring parenteral nutrition.
Development Timeline for Kabiven
|Aug 27, 2014||ApprovalFresenius Kabi Receives FDA Approval for Kabiven and Perikabiven|
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.